RT Journal Article SR Electronic T1 Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus Study JF Canadian Medical Association Journal JO CMAJ FD Canadian Medical Association SP 1953 OP 1958 DO 10.1503/cmaj.100347 VO 182 IS 18 A1 Wendy P.J. den Elzen A1 Jorien M. Willems A1 Rudi G.J. Westendorp A1 Anton J.M. de Craen A1 Gerard Jan Blauw A1 Luigi Ferrucci A1 Willem J.J. Assendelft A1 Jacobijn Gussekloo YR 2010 UL http://www.cmaj.ca/content/182/18/1953.abstract AB Background The production of erythropoietin is triggered by impaired oxygen delivery to the kidney, either because of anemia or hypoxemia. High erythropoietin levels have been shown to predict the risk of death among patients with chronic heart failure. We investigated the prognostic value of elevated erythropoietin levels on mortality among very elderly people in the general population. Methods The Leiden 85-plus Study is a population-based prospective follow-up study involving 599 people aged 85 years in Leiden, the Netherlands, enrolled between September 1997 and September 1999. Erythropoietin levels were determined at age 86. For this analysis, we included 428 participants with a creatinine clearance of at least 30 mL/min. Mortality data, recorded until Feb. 1, 2008, were obtained from the municipal registry. Results During follow-up, 324 (75.7%) participants died. Compared with participants whose erythropoietin levels were in the lowest tertile (reference group), those whose levels were in the middle tertile had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% confidence interval [CI] 0.95–1.64), and those whose levels were in the highest tertile had a 73% increased risk (HR 1.73, 95% CI 1.32–2.26) (p value for trend < 0.01). The association between erythropoietin levels and mortality remained largely unchanged after we adjusted for sex, creatinine clearance, hemoglobin level, comorbidity, smoking status and C-reactive protein level, and was similar for deaths from cardiovascular and noncardiovascular causes. Interpretation Among people aged 85 years and older, elevated erythropoietin levels were associated with an increased risk of death, independent of hemoglobin levels.